journal article·2023-12-11Open access

Magneto-Mechanical Actuation Induces Endothelial Permeability

Mohammad Kanber, Obum Umerah, Stephen Brindley, Xuanyi Zhang, Jared M. Brown, Lew Reynolds, Juan Beltran-Huarac

Abstract

Cancer treatment is one of the major health problems that burden our society. According to the American Cancer Society, over 1.9 million new cancer cases and ∼0.6 million deaths from cancer are expected in the US in 2023. Therapeutic targeting is considered to be the gold standard in cancer treatment. However, when a tumor grows beyond a critical size, its vascular system differentiates abnormally and erratically, creating a heterogeneous endothelial barrier that further restricts drug delivery into tumors. While several methods exist, these prompt tumor migration and the appearance of new metastatic sites. Herein, we propose an innovative method based on magneto-mechanical actuation (MMA) to induce endothelial permeability. This method employs FDA-approved PEGylated superparamagnetic iron oxide nanoparticles (PEG-SPIONs) and alternating nonheating magnetic fields. MMA lies in the translation of magnetic forces into mechanical agitation. As a proof of concept, we developed a 2D cell culture model based on human umbilical vein endothelial cells (HUVEC), which were incubated with PEG-SPIONs and then exposed to different magnetic doses. After adjusting the particle concentration, incubation times, and parameters (amplitude, frequency, and exposure time) of the magnetic field generator, we induced actin filament remodeling and subsequent vascular endothelial-cadherin junction disruption. This led to transient gaps in cell monolayers, through which fluorescein isothiocyanate-dextran was translocated. We observed no cell viability reduction for 3 h of particle incubation up to a concentration of 100 μg/mL in the presence and absence of magnetic fields. For optimal permeability studies, the magnetic field parameters were adjusted to 100 mT, 65 Hz, and 30 min in a pulse mode with 5 min OFF intervals. We found that the endothelial permeability reached the highest value (33%) when 2 h postmagnetic field treatment was used. To explain these findings, a magneto-mechanical transduced stress mechanism mediated by intracellular forces was proposed. This method can open new avenues for targeted drug delivery into anatomic regions within the body for a broad range of disease interventions.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Micro and Nano Robotics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Physics, Howell Science Complex, East Carolina University, Greenville, North Carolina 27858, United States

Brody School of Medicine, East Carolina University, Greenville, North Carolina 27858, United States

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States

Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, United States

Department of Materials Science and Engineering, North Carolina State University, Raleigh, North Carolina 27695, United States

Funding

North Carolina Biotechnology Center · East Carolina University · Research Triangle Nanotechnology Network

References (59)

Show source-provided references
1. 10.1146/annurev-physiol-021909-13583310.1146/annurev-physiol-021909-135833 ↗
2. 10.1152/physrev.00037.201810.1152/physrev.00037.2018 ↗
3. 10.1038/ncomms1559410.1038/ncomms15594 ↗
4. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗
5. 10.1016/j.biomaterials.2022.12164010.1016/j.biomaterials.2022.121640 ↗
6. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
7. 10.1039/c9cs00309f10.1039/c9cs00309f ↗
8. 10.1038/nrc109310.1038/nrc1093 ↗
9. 10.4161/cam.2824310.4161/cam.28243 ↗
10. 10.1016/j.cell.2005.09.02110.1016/j.cell.2005.09.021 ↗
11. 10.1016/j.cell.2005.09.02010.1016/j.cell.2005.09.020 ↗
12. 10.1038/nrm143310.1038/nrm1433 ↗
13. 10.1038/emboj.2011.30410.1038/emboj.2011.304 ↗
14. 10.1038/ncomms265510.1038/ncomms2655 ↗
15. 10.1186/1743-8977-6-110.1186/1743-8977-6-1 ↗
16. 10.1038/s41565-018-0356-z10.1038/s41565-018-0356-z ↗
17. 10.1186/1743-8977-7-1010.1186/1743-8977-7-10 ↗
18. 10.2967/jnumed.116.18136210.2967/jnumed.116.181362 ↗
19. 10.7150/thno.6737510.7150/thno.67375 ↗
20. 10.1186/s11671-017-2084-y10.1186/s11671-017-2084-y ↗
21. 10.1021/acsabm.8b0001610.1021/acsabm.8b00016 ↗
22. 10.1038/s41598-019-42093-110.1038/s41598-019-42093-1 ↗
23. 10.1038/s41598-020-64926-010.1038/s41598-020-64926-0 ↗
24. 10.1021/acsabm.0c0094710.1021/acsabm.0c00947 ↗
25. 10.1021/acsami.3c0017910.1021/acsami.3c00179 ↗
26. 10.1038/srep3356010.1038/srep33560 ↗
27. 10.3390/molecules2301000910.3390/molecules23010009 ↗
28. 10.3390/ijms1604807010.3390/ijms16048070 ↗
29. 10.3103/S106287381311013010.3103/S1062873813110130 ↗
30. 10.1007/s11051-012-1100-510.1007/s11051-012-1100-5 ↗
31. 10.1016/j.apsusc.2006.05.02310.1016/j.apsusc.2006.05.023 ↗
32. 10.1016/j.jssc.2013.01.03710.1016/j.jssc.2013.01.037 ↗
33. 10.1038/srep0502010.1038/srep05020 ↗
34. 10.1021/acsami.7b1864810.1021/acsami.7b18648 ↗
35. 10.1016/j.biomaterials.2011.08.04810.1016/j.biomaterials.2011.08.048 ↗
36. 10.2147/IJN.S19221410.2147/IJN.S192214 ↗
37. 10.1016/j.toxlet.2015.10.01810.1016/j.toxlet.2015.10.018 ↗
38. 10.2147/IJN.S8327910.2147/IJN.S83279 ↗
39. 10.1016/j.nano.2021.10245910.1016/j.nano.2021.102459 ↗
40. 10.1093/rb/rbz02410.1093/rb/rbz024 ↗
41. 10.2217/nnm.15.1410.2217/nnm.15.14 ↗
42. 10.1039/D2NR02210A10.1039/D2NR02210A ↗
43. 10.1080/02656736.2019.156578710.1080/02656736.2019.1565787 ↗
44. 10.2147/IJN.S32198410.2147/IJN.S321984 ↗
45. 10.7150/ntno.1830310.7150/ntno.18303 ↗
46. 10.1186/1471-2202-14-5910.1186/1471-2202-14-59 ↗
47. 10.3390/mps501001710.3390/mps5010017 ↗
48. 10.1086/67735610.1086/677356 ↗
49. 10.1146/annurev-physiol-021909-13583310.1146/annurev-physiol-021909-135833 ↗
50. 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-810.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8 ↗
51. 10.3389/fphys.2020.0086110.3389/fphys.2020.00861 ↗
52. 10.7150/thno.356810.7150/thno.3568 ↗
53. 10.1186/s12989-019-0314-410.1186/s12989-019-0314-4 ↗
54. 10.1002/jbm.a.3297210.1002/jbm.a.32972 ↗
55. 10.1152/ajpcell.00457.200610.1152/ajpcell.00457.2006 ↗
56. 10.1091/mbc.e13-07-040410.1091/mbc.e13-07-0404 ↗
57. 10.1021/acsomega.0c0616410.1021/acsomega.0c06164 ↗
58. 10.1016/j.matlet.2013.02.04210.1016/j.matlet.2013.02.042 ↗
59. 10.1002/adfm.20230551910.1002/adfm.202305519 ↗